Fennec Pharmaceuticals Inc. revenue breakdown overview

Fennec Pharmaceuticals Inc. revenue for the last year amounted to 47.67 M USD, the most of which — 45.26 M USD — came from its highest performing source at the moment, Sodium Thiosulfate Injection, the year earlier bringing 21.64 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Fennec Pharmaceuticals Inc. 45.26 M USD, and the year before that — 21.64 M USD.